Tudor Investment Corp ET AL Makes New Investment in Novanta Inc. $NOVT

Tudor Investment Corp ET AL acquired a new position in shares of Novanta Inc. (NASDAQ:NOVTFree Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 53,962 shares of the technology company’s stock, valued at approximately $5,404,000.

Other hedge funds have also recently bought and sold shares of the company. Pilgrim Partners Asia Pte Ltd purchased a new position in Novanta during the 3rd quarter worth $36,000. Danske Bank A S bought a new position in Novanta during the third quarter valued at about $40,000. Migdal Insurance & Financial Holdings Ltd. bought a new position in Novanta during the third quarter valued at about $40,000. Caitong International Asset Management Co. Ltd bought a new position in Novanta during the third quarter valued at about $81,000. Finally, Harbor Investment Advisory LLC grew its position in Novanta by 47.1% during the third quarter. Harbor Investment Advisory LLC now owns 987 shares of the technology company’s stock valued at $99,000 after buying an additional 316 shares during the period. 98.35% of the stock is owned by hedge funds and other institutional investors.

Novanta Trading Up 6.2%

Shares of NOVT opened at $122.44 on Thursday. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. The business’s 50-day moving average price is $130.04 and its 200-day moving average price is $121.44. The stock has a market cap of $4.37 billion, a PE ratio of 83.86 and a beta of 1.64. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $149.95.

Novanta (NASDAQ:NOVTGet Free Report) last posted its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.03. The company had revenue of $258.35 million for the quarter, compared to analysts’ expectations of $260.72 million. Novanta had a net margin of 5.49% and a return on equity of 13.12%. During the same period in the prior year, the business earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, equities analysts forecast that Novanta Inc. will post 3.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on NOVT. Robert W. Baird upgraded shares of Novanta from a “neutral” rating to an “outperform” rating and reduced their price target for the company from $150.00 to $144.00 in a research report on Monday, March 30th. Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 20th. Wall Street Zen upgraded shares of Novanta from a “hold” rating to a “buy” rating in a research report on Saturday, April 4th. Finally, Zacks Research upgraded Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $144.00.

View Our Latest Research Report on NOVT

Insider Activity at Novanta

In related news, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total value of $1,087,800.00. Following the transaction, the chief executive officer directly owned 57,367 shares in the company, valued at approximately $8,320,509.68. This represents a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Robert Buckley sold 9,957 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $116.77, for a total transaction of $1,162,678.89. Following the completion of the transaction, the chief financial officer owned 96,616 shares in the company, valued at approximately $11,281,850.32. This trade represents a 9.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 33,980 shares of company stock worth $4,503,380. 1.20% of the stock is owned by company insiders.

About Novanta

(Free Report)

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.

Featured Articles

Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVTFree Report).

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.